NSG 620 Exam 3 latest
NSG 620 Exam 3 latest 2024/2025
Which HPV types are most likely to cause genital condyloma acuminatum?
A. 1, 2, and 3
B. 6 and 11
C. 16 and 18
D. 22 and 24 - B.
The use of combined oral contraception (COC) reduces menstrual volume by approximately 60%,
thereby reducing the risk of iron deficiency anemia.
A. True
B. False - A.
When prescribing the contraceptive patch (Ortho Evra) or vaginal ring (NuvaRing), the NP considers that:
A. these are progestin-only products.
B. candidates include women who have difficulty remembering to take a daily pill.
C. there is significant drug interactions with both products.
D. contraceptive efficacy is less than with COC. - B.
110.According to the U. S. Medical Eligibility Criteria for Contraception Use , is a 22-year-old who smokes
one pack per day a category 1 or 2 COC candidate?
A. Yes
B. No - A.
,NSG 620 Exam 3 latest
No contraceptive benefits of COC use include a decrease in all of the following except:
A. iron-deficiency anemia.
B. pelvic inflammatory disease (PID).
C. cervicitis.
D. ovarian cancer. - C.
For a woman with bothersome hot flashes who cannot take HT, alternative options with demonstrated
efficacy and limited adverse effects include the use of all of the following except:
A. venlafaxine.
B. sertraline.
C. gabapentin.
D. clonidine. -
As you prescribe COC containing the progestin domperidone (Lorina, Ocelli, Vesture, Yasmin, Yas), you
offer the following advice:
A. "Always take this pill on a full stomach. "B. "You should not take acetaminophen when using this birth
control pill. "
C. "Avoid using potassium-containing salt substitutes. "
D. "You will likely notice that premenstrual syndrome symptoms might become worse. " - C.
With DMPA in depot injection (Depo-Provera), the recommended length of use is usually:
A. less than 1 year.
B. no more than 2 years.
C. as long as the woman desires this form of contraception.
,NSG 620 Exam 3 latest
D. as determined by her lipid response to the medication. - B.
In advising a perimenopausal woman about HT, you consider that it may:
A. reduce the risk of venous thrombotic events. B. significantly reduce serum triglyceride levels.
C. worsen hypertension in most women.
D. help preserve bone density. - D.
According to the U. S. Medical Eligibility Criteria for Contraception Use, is a 33-year-old with low-grade
squamous intraepithelial lesions noted on Pap test a candidate for a copper-containing IUD?
A. Yes
B. No. - A.
When reviewing the use of nutritional supplements for the management of menopausal symptoms, the
NP considers that:
A. few high-quality studies support the use of these products.
B. the use of these products is consistently reported to be helpful.
C. the products can be safely used as long as blood hormone levels are carefully evaluated.
D. the use of these products is associated with a greater reduction in menopausal symptoms than
with prescription HT. - A.
A 48-year-old woman complains of increased frequency and severity of hot flashes. Her last menses
occurred 6 months ago. You would expect all of the following laboratory findings except:
A. increased levels of LH.
B. elevated levels of testosterone.
C. reduced levels of estradiol.
, NSG 620 Exam 3 latest
D. reduced levels of progesterone. - B.
Diagnostic testing of a person with primary HSV-2 infection would likely show:
A. negative virological and serological test results.
B. negative virological test result and positive serological test result.
C. positive virological test result and negative serological test result.
D. positive virological and serological test results. - C.
According to the U. S. Medical Eligibility Criteria for Contraception Use, which of the following is a
clinical condition in which use of a copper-containing IUD should be approached with caution?
A. uncomplicated valvular heart disease
B. AIDS-defining illness
C. hypertension
D. dysmenorrhea - B.
Concerning selective estrogen receptor modulator therapy such as raloxifene (Evista), which of the
following statements is correct?
A. Concurrent progestin opposition is needed.
B. Hot flashes are reduced in frequency and severity.
C. Use is contraindicated when a woman has a history of breast cancer. D. Osteoporosis risk is
reduced with use. - D
A sexually active woman should be aware that genital herpes simplex virus:
NSG 620 Exam 3 latest 2024/2025
Which HPV types are most likely to cause genital condyloma acuminatum?
A. 1, 2, and 3
B. 6 and 11
C. 16 and 18
D. 22 and 24 - B.
The use of combined oral contraception (COC) reduces menstrual volume by approximately 60%,
thereby reducing the risk of iron deficiency anemia.
A. True
B. False - A.
When prescribing the contraceptive patch (Ortho Evra) or vaginal ring (NuvaRing), the NP considers that:
A. these are progestin-only products.
B. candidates include women who have difficulty remembering to take a daily pill.
C. there is significant drug interactions with both products.
D. contraceptive efficacy is less than with COC. - B.
110.According to the U. S. Medical Eligibility Criteria for Contraception Use , is a 22-year-old who smokes
one pack per day a category 1 or 2 COC candidate?
A. Yes
B. No - A.
,NSG 620 Exam 3 latest
No contraceptive benefits of COC use include a decrease in all of the following except:
A. iron-deficiency anemia.
B. pelvic inflammatory disease (PID).
C. cervicitis.
D. ovarian cancer. - C.
For a woman with bothersome hot flashes who cannot take HT, alternative options with demonstrated
efficacy and limited adverse effects include the use of all of the following except:
A. venlafaxine.
B. sertraline.
C. gabapentin.
D. clonidine. -
As you prescribe COC containing the progestin domperidone (Lorina, Ocelli, Vesture, Yasmin, Yas), you
offer the following advice:
A. "Always take this pill on a full stomach. "B. "You should not take acetaminophen when using this birth
control pill. "
C. "Avoid using potassium-containing salt substitutes. "
D. "You will likely notice that premenstrual syndrome symptoms might become worse. " - C.
With DMPA in depot injection (Depo-Provera), the recommended length of use is usually:
A. less than 1 year.
B. no more than 2 years.
C. as long as the woman desires this form of contraception.
,NSG 620 Exam 3 latest
D. as determined by her lipid response to the medication. - B.
In advising a perimenopausal woman about HT, you consider that it may:
A. reduce the risk of venous thrombotic events. B. significantly reduce serum triglyceride levels.
C. worsen hypertension in most women.
D. help preserve bone density. - D.
According to the U. S. Medical Eligibility Criteria for Contraception Use, is a 33-year-old with low-grade
squamous intraepithelial lesions noted on Pap test a candidate for a copper-containing IUD?
A. Yes
B. No. - A.
When reviewing the use of nutritional supplements for the management of menopausal symptoms, the
NP considers that:
A. few high-quality studies support the use of these products.
B. the use of these products is consistently reported to be helpful.
C. the products can be safely used as long as blood hormone levels are carefully evaluated.
D. the use of these products is associated with a greater reduction in menopausal symptoms than
with prescription HT. - A.
A 48-year-old woman complains of increased frequency and severity of hot flashes. Her last menses
occurred 6 months ago. You would expect all of the following laboratory findings except:
A. increased levels of LH.
B. elevated levels of testosterone.
C. reduced levels of estradiol.
, NSG 620 Exam 3 latest
D. reduced levels of progesterone. - B.
Diagnostic testing of a person with primary HSV-2 infection would likely show:
A. negative virological and serological test results.
B. negative virological test result and positive serological test result.
C. positive virological test result and negative serological test result.
D. positive virological and serological test results. - C.
According to the U. S. Medical Eligibility Criteria for Contraception Use, which of the following is a
clinical condition in which use of a copper-containing IUD should be approached with caution?
A. uncomplicated valvular heart disease
B. AIDS-defining illness
C. hypertension
D. dysmenorrhea - B.
Concerning selective estrogen receptor modulator therapy such as raloxifene (Evista), which of the
following statements is correct?
A. Concurrent progestin opposition is needed.
B. Hot flashes are reduced in frequency and severity.
C. Use is contraindicated when a woman has a history of breast cancer. D. Osteoporosis risk is
reduced with use. - D
A sexually active woman should be aware that genital herpes simplex virus:
